Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
11.79
-1.11 (-8.60%)
At close: Mar 11, 2026, 4:00 PM EDT
12.02
+0.23 (1.95%)
After-hours: Mar 11, 2026, 7:28 PM EDT
Elicio Therapeutics Employees
Elicio Therapeutics had 32 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
32
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,433,031
Market Cap
206.03M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 32 | 0 | - |
| Dec 31, 2023 | 32 | 9 | 39.13% |
| Dec 31, 2022 | 23 | -1 | -4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 166 |
| Caribou Biosciences | 147 |
| Arcturus Therapeutics Holdings | 111 |
| Vaxart | 105 |
| Tenaya Therapeutics | 97 |
| Compugen | 74 |
| Acumen Pharmaceuticals | 61 |
| Whitehawk Therapeutics | 22 |
ELTX News
- 14 days ago - Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 21 days ago - Elicio Therapeutics Reports Inducement Grants - GlobeNewsWire
- 3 months ago - Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial - GlobeNewsWire
- 4 months ago - Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer - GlobeNewsWire
- 4 months ago - Elicio Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - Elicio Therapeutics: Running On Fumes, But A Definitive Readout Appears Imminent - Seeking Alpha
- 4 months ago - Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC - GlobeNewsWire
- 4 months ago - Elicio Therapeutics to Present Clinical and Preclinical Data at the SITC 2025 Annual Meeting - GlobeNewsWire